Stock Market Movers: Top Gainers And Losers Today

6 min read
2 views
Aug 4, 2025

Which stocks soared and which stumbled today? From Figma's sharp drop to CommScope's massive gain, uncover the market's biggest moves and what they mean for investors. Click to find out!

Financial market analysis from 04/08/2025. Market conditions may have changed since publication.

Ever wonder what makes the stock market tick on any given day? It’s like watching a high-stakes game where some players soar to new heights while others take a hit. Today’s market was no exception, with companies like Figma, CommScope, and Joby Aviation stealing the spotlight for wildly different reasons. Let’s dive into the action, unpack the biggest movers, and explore what these shifts might mean for your investment strategy.

Today’s Stock Market: A Rollercoaster of Gains and Losses

The stock market is never dull, and today proved it with a whirlwind of activity. From tech startups to retail giants, companies across sectors made headlines with dramatic price swings. Whether driven by earnings reports, acquisitions, or unexpected news, these movements offer a window into the forces shaping the financial markets. Let’s break down the day’s biggest winners and losers, and why they matter.


Figma’s Fall: A Post-IPO Reality Check

Figma, the design software darling, took a rough tumble today, shedding 22% of its value. After a dazzling IPO last week that saw its stock triple on debut, this drop feels like a cold splash of reality. The initial hype around Figma’s public offering was electric, but today’s slide suggests investors are reassessing its sky-high valuation.

What’s behind the drop? Some say it’s a natural correction after the IPO frenzy, while others point to broader market volatility. I’ve seen this before—newly public companies often ride a wave of excitement only to face scrutiny once the dust settles. For investors, this could be a chance to buy in at a lower price, but caution is key.

Post-IPO corrections are common as markets recalibrate expectations.

– Financial analyst

CommScope’s Massive Surge: A $10.5 Billion Deal

On the flip side, CommScope was the day’s superstar, rocketing 75% after news broke of a major deal. Amphenol, a cable parts supplier, agreed to acquire CommScope’s connectivity and cable solutions business for a hefty $10.5 billion in cash. This kind of blockbuster acquisition doesn’t happen every day, and investors clearly saw dollar signs.

The deal, set to close by mid-2026, positions Amphenol to dominate the connectivity space. For CommScope shareholders, it’s a windfall, but it also raises questions about the company’s future without this key division. Could this be a turning point for both companies? Only time will tell.

  • Deal Value: $10.5 billion in cash
  • Expected Close: First half of 2026
  • Impact: Strengthens Amphenol’s market position

Joby Aviation Soars with Strategic Acquisition

Joby Aviation, a pioneer in electric aircraft, climbed 20% after announcing its acquisition of Blade’s passenger business for $125 million. This move is a big step toward launching commercial operations in Dubai and expanding globally. The market loved the news, and it’s easy to see why—Joby’s positioning itself as a leader in the urban air mobility sector.

I’m personally excited about this one. The idea of electric air taxis zipping through city skies feels like something out of a sci-fi movie, yet Joby’s making it real. This acquisition could accelerate their rollout, but scaling such a futuristic business comes with risks. Investors seem optimistic, but will the hype translate to profits?

This acquisition is a game-changer for Joby’s global ambitions.

– Industry insider

Fortrea’s Long-Term Bet Pays Off

Fortrea, a pharmaceutical services company, jumped 21% after a glowing upgrade from Baird analysts. They called it a “long-term compounding opportunity,” focusing on its potential for steady growth rather than short-term gains. It’s a reminder that not every stock move is about immediate results—sometimes, it’s about the bigger picture.

Baird’s confidence stems from Fortrea’s role in the pharma industry, where innovation drives value. For investors with patience, this could be a gem. But in a market obsessed with quick wins, can Fortrea keep the momentum going?

Idexx Laboratories: Beating Expectations

Idexx Laboratories, a leader in health-care diagnostics, surged 26% after smashing second-quarter expectations. With earnings of $3.63 per share and revenue of $1.11 billion, the company outperformed Wall Street’s forecasts. This kind of beat can ignite investor confidence, and today’s rally proves it.

What’s driving Idexx’s success? Their focus on diagnostic innovation is paying off, especially in the growing pet healthcare market. As someone who’s seen how much people spend on their pets, I’m not surprised—Idexx is tapping into a goldmine. But can they sustain this growth in a competitive field?

CompanyStock MoveKey Driver
Figma-22%Post-IPO correction
CommScope+75%$10.5B acquisition by Amphenol
Joby Aviation+20%Blade acquisition
Idexx Laboratories+26%Strong Q2 earnings

American Eagle’s Unexpected Boost

American Eagle Outfitters soared nearly 20% after a surprising shoutout from a high-profile figure praising their ad campaign featuring actress Sydney Sweeney. The campaign stirred some controversy, with critics calling it tone-deaf, but the market clearly didn’t care. Sometimes, buzz—good or bad—drives stock prices.

This one caught me off guard. Retail is a tough space, and American Eagle’s been navigating choppy waters. The lesson here? Never underestimate the power of a viral moment, even if it’s polarizing. But will this spike hold, or is it just a flash in the pan?

TG Therapeutics: A Miss That Stung

Not every stock had a great day. TG Therapeutics slid almost 15% after reporting second-quarter earnings that fell short of expectations. With earnings of 17 cents per share against Wall Street’s hoped-for 21 cents, the biotech company disappointed investors. It’s a harsh reminder that the biotech sector is a high-risk game.

Biotech stocks are like rollercoasters—thrilling when they climb, gut-wrenching when they drop. TG’s miss highlights the challenges of drug development timelines. For risk-tolerant investors, this dip might be a buying opportunity, but it’s not for the faint of heart.

Energizer’s Bright Outlook

Energizer, the battery giant, charged up 24% after a strong third-quarter performance and an upbeat full-year outlook. The company raised its earnings guidance to $3.55-$3.65 per share, topping analyst expectations. It’s not just about batteries; Energizer’s proving it can adapt in a competitive market.

I’ll admit, I didn’t expect Energizer to shine so brightly. Their ability to exceed forecasts in a seemingly mundane industry shows the power of solid execution. Could this be a sign of more gains to come, or is the stock fully charged for now?

Wayfair’s Winning Streak

Wayfair, the online furniture retailer, surged 11% after crushing Wall Street’s second-quarter expectations. With adjusted earnings of 87 cents per share and revenue of $3.27 billion, Wayfair outperformed forecasts and showed resilience in a tough retail environment.

E-commerce is a brutal space, but Wayfair’s focus on customer experience seems to be paying off. I’ve always thought their knack for offering trendy furniture at accessible prices gives them an edge. This rally suggests they’re on the right track, but retail’s volatility keeps things unpredictable.

Berkshire Hathaway’s Slight Dip

Even the mighty Berkshire Hathaway wasn’t immune to today’s market swings, dipping about 3%. A 4% drop in operating profit, driven by weaker insurance underwriting, put pressure on the stock. Still, with a cash pile of $344.1 billion, Warren Buffett’s conglomerate remains a titan.

Seeing Berkshire take a hit feels like watching an oak tree sway in the wind—unsettling, but you know it’s not going anywhere. Their long-term strategy of value investing keeps them steady, but today’s dip might spook short-term traders.

What These Moves Mean for Investors

Today’s market action is a masterclass in diversity—some stocks soared on strategic moves, others stumbled on missed expectations. For investors, it’s a chance to reflect on what drives stock performance. Are you chasing short-term gains, or building a portfolio for the long haul?

  1. Stay Informed: Track earnings reports and major deals to spot opportunities.
  2. Assess Risk: High flyers like Joby come with big risks but big rewards.
  3. Think Long-Term: Stocks like Fortrea reward patience over speculation.

The stock market’s like a living, breathing puzzle—every piece tells a story. Today’s movers, from CommScope’s acquisition-driven surge to Figma’s post-IPO slump, remind us that opportunity and risk go hand in hand. What’s your next move?


Markets are unpredictable, but that’s what makes them exciting. Whether you’re eyeing a dip in Figma or banking on Joby’s futuristic vision, today’s action offers plenty to chew on. Keep your eyes on the trends, and maybe you’ll spot the next big winner.

The only investors who shouldn't diversify are those who are right 100% of the time.
— Sir John Templeton
Author

Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.

Related Articles